Trial of a Culturally Tailored Lung Health Program to Help Chinese and Korean American Smokers Quit and Improve Lung Screening

What this Trial Is About

Researchers are evaluating a counseling and educational program aimed at improving lung health by helping Chinese and Korean American smokers at high risk for lung cancer to quit smoking. This randomized clinical trial compares the effectiveness of the ACT Lung Health Intervention with standard care, focusing on smoking cessation and lung cancer screening behaviors. Participants will be randomly assigned to one of two groups. Group A receives the ACT Lung Health Intervention, which includes eight weekly counseling sessions via phone or video, family coaching, nicotine replacement therapy patches, gum, lozenges, and educational materials about lung cancer screening with low-dose computed tomography LDCT. Group B receives standard care with six counseling sessions, nicotine replacement therapy, and educational materials. Both groups undergo assessments at baseline, 1, 3, and 6 months, including saliva tests at 3 and 6 months. Participants will complete questionnaires and saliva tests to monitor smoking abstinence and lung cancer screening completion. The primary outcome is biochemically verified smoking abstinence at 6 months. Secondary outcomes include changes in cigarette consumption, self-reported abstinence at 3 and 6 months, and lung cancer screening completion. The study lasts approximately 6 months and involves about 50 participants, with safety monitored throughout the trial.

ACT Lung Health Intervention: Phase Two